These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26374742)

  • 1. A conceptual disease model for adult Pompe disease.
    Kanters TA; Redekop WK; Rutten-Van Mölken MP; Kruijshaar ME; Güngör D; van der Ploeg AT; Hakkaart L
    Orphanet J Rare Dis; 2015 Sep; 10():112. PubMed ID: 26374742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exercise training in adults with Pompe disease: the effects on pain, fatigue, and functioning.
    Favejee MM; van den Berg LE; Kruijshaar ME; Wens SC; Praet SF; Pim Pijnappel WW; van Doorn PA; Bussmann JB; van der Ploeg AT
    Arch Phys Med Rehabil; 2015 May; 96(5):817-22. PubMed ID: 25499687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severely impaired health status at diagnosis of Pompe disease: a cross-sectional analysis to explore the potential utility of neonatal screening.
    Rigter T; Weinreich SS; van El CG; de Vries JM; van Gelder CM; Güngör D; Reuser AJ; Hagemans ML; Cornel MC; van der Ploeg AT
    Mol Genet Metab; 2012 Nov; 107(3):448-55. PubMed ID: 23040796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life in advanced prostate cancer and its treatments: biochemical failure and metastatic disease populations.
    Sartor O; Flood E; Beusterien K; Park J; Webb I; MacLean D; Wong BJ; Mark Lin H
    Clin Genitourin Cancer; 2015 Apr; 13(2):101-12. PubMed ID: 25262852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive association between physical outcomes and patient-reported outcomes in late-onset Pompe disease: a cross sectional study.
    Yuan M; Andrinopoulou ER; Kruijshaar ME; Lika A; Harlaar L; van der Ploeg AT; Rizopoulos D; van der Beek NAME
    Orphanet J Rare Dis; 2020 Sep; 15(1):232. PubMed ID: 32883321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pain in adult patients with Pompe disease: a cross-sectional survey.
    Güngör D; Schober AK; Kruijshaar ME; Plug I; Karabul N; Deschauer M; van Doorn PA; van der Ploeg AT; Schoser B; Hanisch F
    Mol Genet Metab; 2013 Aug; 109(4):371-6. PubMed ID: 23849261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consequences of chronic obstructive pulmonary disease and chronic heart failure: the relationship between objective and subjective health.
    Arnold R; Ranchor AV; Koëter GH; de Jongste MJ; Sanderman R
    Soc Sci Med; 2005 Nov; 61(10):2144-54. PubMed ID: 15927333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review of the application of Wilson and Cleary health-related quality of life model in chronic diseases.
    Ojelabi AO; Graham Y; Haighton C; Ling J
    Health Qual Life Outcomes; 2017 Dec; 15(1):241. PubMed ID: 29228977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A conceptual disease model for quality of life in mitochondrial disease.
    van de Loo KFE; van Zeijl NT; Custers JAE; Janssen MCH; Verhaak CM
    Orphanet J Rare Dis; 2022 Jul; 17(1):263. PubMed ID: 35841006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of late-onset Pompe disease on participation in daily life activities: evaluation of the Rotterdam Handicap Scale.
    Hagemans ML; Laforêt P; Hop WJ; Merkies IS; Van Doorn PA; Reuser AJ; Van der Ploeg AT
    Neuromuscul Disord; 2007 Jul; 17(7):537-43. PubMed ID: 17475490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of informal care for patients with Pompe disease: an application of the CarerQol instrument.
    Kanters TA; van der Ploeg AT; Brouwer WB; Hakkaart L
    Mol Genet Metab; 2013 Nov; 110(3):281-6. PubMed ID: 23973269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Rasch-built Pompe-specific activity (R-PAct) scale.
    van der Beek NA; Hagemans ML; van der Ploeg AT; van Doorn PA; Merkies IS
    Neuromuscul Disord; 2013 Mar; 23(3):256-64. PubMed ID: 23273871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Access to orphan drugs in western Europe: can more systematic policymaking really help to avoid different decisions about the same drug?
    Kanters TA; Hakkaart L; Rutten-van Mölken MP; Redekop WK
    Expert Rev Pharmacoecon Outcomes Res; 2015; 15(4):557-9. PubMed ID: 25973903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycogen storage disease type II (Pompe disease)--influence of enzyme replacement therapy in adults.
    Merk T; Wibmer T; Schumann C; Krüger S
    Eur J Neurol; 2009 Feb; 16(2):274-7. PubMed ID: 19138339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pompe disease: a neuromuscular disease with respiratory muscle involvement.
    Mellies U; Lofaso F
    Respir Med; 2009 Apr; 103(4):477-84. PubMed ID: 19131232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remarkably low fibroblast acid α-glucosidase activity in three adults with Pompe disease.
    Wens SC; Kroos MA; de Vries JM; Hoogeveen-Westerveld M; Wijgerde MG; van Doorn PA; van der Ploeg AT; Reuser AJ
    Mol Genet Metab; 2012 Nov; 107(3):485-9. PubMed ID: 23000108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes.
    Wilson IB; Cleary PD
    JAMA; 1995 Jan; 273(1):59-65. PubMed ID: 7996652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing disease severity in Pompe disease: the roles of a urinary glucose tetrasaccharide biomarker and imaging techniques.
    Young SP; Piraud M; Goldstein JL; Zhang H; Rehder C; Laforet P; Kishnani PS; Millington DS; Bashir MR; Bali DS
    Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):50-8. PubMed ID: 22252961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac evaluation in children and adults with Pompe disease sharing the common c.-32-13T>G genotype rarely reveals abnormalities.
    van der Beek NA; Soliman OI; van Capelle CI; Geleijnse ML; Vletter WB; Kroos MA; Reuser AJ; Frohn-Mulder IM; van Doorn PA; van der Ploeg AT
    J Neurol Sci; 2008 Dec; 275(1-2):46-50. PubMed ID: 18757064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.